 | Up a level |
Journal Article
Goto, K., Wolf, J., Elamin, Y., Santini, F., Soldatenkova, V., Sashegyi, A., Lin, A. Bence, Lin, B., Novello, S., Arriola Aperribay, E., Perol, M., Loong, H., Drilon, A., Park, K., Solomon, B. and Zhou, C. (2021). LIBRETTO-431: Selpercatinib in Treatment-Naive Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC). J. Thorac. Oncol., 16 (3). S. S228 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Loong, H. H. F., Goto, K., Elamin, Y. Y., Solomon, B., Santini, F. C., Soldatenkova, V., Sashegyi, A., Lin, A. Bence, Lin, B. K., Wolf, J., Oxnard, G. R., Zhou, C., Drilon, A. and Park, K. (2020). LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET plus ) non-small cell lung cancer (NSCLC). Ann. Oncol., 31. S. S893 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Solomon, B. J., Loong, H. H., Summers, Y., Thomas, Z. M., French, P., Lin, B. K., Sashegyi, A., Wolf, J., Yang, J. C-H and Drilon, A. (2022). Correlation between treatment effects on response rate and progression-free survival and overall survival in trials of targeted therapies in molecularly enriched populations. ESMO Open, 7 (2). AMSTERDAM: ELSEVIER. ISSN 2059-7029